4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-053379
Director sold 120,592 shares at an average $29.29 ($3,531,820)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GADICKE ANSBERT Director | 2021-08-23 | Sale | −7,376 | $29.11 | $214,715 | 273,545 | D |
| GADICKE ANSBERT Director | 2021-08-23 | Sale | −53,359 | $29.11 | $1,553,280 | 7,858,018 | I |
| GADICKE ANSBERT Director | 2021-08-24 | Sale | −7,025 | $29.48 | $207,097 | 266,520 | D |
| GADICKE ANSBERT Director | 2021-08-24 | Sale | −50,882 | $29.48 | $1,500,001 | 7,807,196 | I |
| GADICKE ANSBERT Director | 2021-08-25 | Sale | −237 | $29.09 | $6,894 | 266,283 | D |
| GADICKE ANSBERT Director | 2021-08-25 | Sale | −1,713 | $29.09 | $49,831 | 7,805,483 | I |
| Open-market sales · 120,592 sh · avg $29.29 · $3,531,820 | |||||||
Loading xslF345X03/doc4.xml…